Skip to main content
. 2012 Sep 3;6:371–375. doi: 10.2174/1874325001206010371

Table 3.

Tissue Volume Fractions

New Bone (%) TCP (%) Fibrous Tissue (%)
Control 14.19 (13.00;17.25) 10.29 (9.53;11.43) 16.44 (8.21;18.54)
Zoledronate 16.84 (12.34;19.23) 12.11 (8.39;14.23) 14.70 (5.55;22.13)
p-value 0.58 0.80 0.88

Data are presented as median for each treatment group with interquartile range in parenthesis.